December 2023 Stock Gainers on News

Ranked by the close-to-close change of the trading session each announcement landed in. How this is measured.

Data as of the trading session of 2023-12-29, 20 of 20 completed market sessions produced ranked moves. That date is the last ranked session, not the last priced one, so follow-through dates run later.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

See the biggest losers of December 2023

100

Ranked gains

+295.87%

Largest, MLGO

89.9%

Above baseline, day +5

0.3%

Median give-back, day +5

Filter and sort

100 ranked gains in December 2023

Skip the ranked rows and go to the month summary

Every percentage on a row, the follow-through readings included, is measured against that row's own pre-news close, which the row names. A day +5 reading is therefore the move from before the announcement, not a further change on top of the headline percentage.

Rank	Symbol	close to close	Session	Catalyst	Announcement	from the pre-news close
1	MLGO Also on the opposite board this month on both boards	+295.87%	2023-12-06 against the close of 2023-12-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	MicroAlgo Inc. Announced That Its Company Will Establish A Postgraduate Training Practice Base 12/06/2023 06:00 ET premarket MicroAlgo Inc. announced plans to establish a practice base to train graduate students for the university 12/06/2023	Day +1 -15.29% 2023-12-07 Day +5 -15.29% 2023-12-13 Best close within 5 -6.61% 2023-12-08 It gave back the whole move and closed 15.29% below the pre-news price. Month end -62.31% on 2023-12-29
Close before and after $14,520.00 to $57,480.00 split-adjusted Session open, high, low $24,780.00, $64,560.00, $22,380.00 Opening gap +70.66% Close inside the session range 0.83 of the range, where 1.00 is the high Session volume 13,186 shares, $757,931,280 Relative volume 517.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
2	SSNT	+240.33%	2023-12-04 against the close of 2023-12-01 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	Brad Jacobs to Lead Equity Investment of $1 Billion in SilverSun Technologies and Pursue Acquisitions in an Industry to be Announced Later 12/04/2023 07:00 ET premarket	Day +1 +168.39% 2023-12-05 Day +5 +196.46% 2023-12-11 Best close within 5 +196.46% 2023-12-11 18.3% of the move was gone five sessions later. Month end +366.21% on 2023-12-29
Close before and after $29.36 to $99.92 as traded Session open, high, low $66.32, $106.96, $51.84 Opening gap +125.89% Close inside the session range 0.87 of the range, where 1.00 is the high Session volume 5,205,425 shares, $520,126,066 Relative volume over 1,000x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
3	ROI Also on the opposite board this month on both boards	+205.40%	2023-12-27 against the close of 2023-12-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	RiskOn International to Announce Its New Generative AI Platform and Technology Partner on January 3, 2024 12/27/2023 08:30 ET premarket	Day +1 +102.41% 2023-12-28 Day +5 +66.55% 2024-01-04 Best close within 5 +225.99% 2024-01-02 67.6% of the move was gone five sessions later. Month end +136.29% on 2023-12-29 This month ended before the fifth session after the move.
Close before and after $0.1408 to $0.4300 as traded Session open, high, low $0.2075, $0.5320, $0.1900 Opening gap +47.37% Close inside the session range 0.70 of the range, where 1.00 is the high Session volume 143,365,159 shares, $61,647,018 Relative volume 83.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
4	HA	+192.59%	2023-12-04 against the close of 2023-12-01 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Alaska Airlines and Hawaiian Airlines to Combine, Expanding Benefits and Choice for Travelers Throughout Hawai'i and the West Coast 12/03/2023 14:00 ET intraday	Day +1 +185.80% 2023-12-05 Day +5 +174.28% 2023-12-11 Best close within 5 +185.80% 2023-12-05 9.5% of the move was gone five sessions later. Month end +192.18% on 2023-12-29
Close before and after $4.86 to $14.22 as traded Session open, high, low $13.59, $14.25, $13.22 Opening gap +179.63% Close inside the session range 0.97 of the range, where 1.00 is the high Session volume 35,562,721 shares, $505,701,893 Relative volume 15.4x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
5	LTRY	+180.17%	2023-12-21 against the close of 2023-12-20 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Lottery.com Inc. Announces $18 Million Commitment from Prosperity Investment Management 12/21/2023 13:00 ET intraday	Day +1 +113.76% 2023-12-22 Day +5 +106.89% 2023-12-29 Best close within 5 +118.34% 2023-12-28 40.7% of the move was gone five sessions later. Month end +106.89% on 2023-12-29
Close before and after $1.31 to $3.67 as traded Session open, high, low $1.25, $7.01, $1.25 Opening gap -4.57% Close inside the session range 0.42 of the range, where 1.00 is the high Session volume 12,139,145 shares, $44,550,662 Relative volume 830.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
6	EYPT	+177.46%	2023-12-04 against the close of 2023-12-01 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	EyePoint Pharmaceuticals Announces Positive Topline Data from the Phase 2 DAVIO 2 Trial of EYP-1901 in Wet AMD Achieving All Primary and Secondary Endpoints 12/04/2023 07:00 ET premarket	Day +1 +168.38% 2023-12-05 Day +5 +202.12% 2023-12-11 Best close within 5 +220.42% 2023-12-07 Five sessions later the move was 13.9% bigger, at +202.12%. Month end +249.62% on 2023-12-29
Close before and after $6.61 to $18.34 split-adjusted Session open, high, low $22.00, $22.44, $17.31 Opening gap +232.83% Close inside the session range 0.20 of the range, where 1.00 is the high Session volume 20,827,293 shares, $381,972,554 Relative volume 38.7x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
7	CGEN	+173.97%	2023-12-19 against the close of 2023-12-18 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Gilead and Compugen Announce Exclusive License Agreement for Novel Pre-Clinical Immunotherapy Program 12/19/2023 07:00 ET premarket Compugen will be Eligible to Receive $10 Million Milestone Payment upon Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer 12/19/2023 Compugen to Host Conference Call to Discuss Exclusive License Agreement with Gilead for COM503, Novel Immuno-Oncology Pre-Clinical Program Harnessing IL-18 Biology 12/19/2023	Day +1 +153.42% 2023-12-20 Day +5 +142.47% 2023-12-27 Best close within 5 +153.42% 2023-12-20 18.1% of the move was gone five sessions later. Month end +171.23% on 2023-12-29
Close before and after $0.7300 to $2.00 split-adjusted Session open, high, low $2.03, $2.46, $1.61 Opening gap +178.08% Close inside the session range 0.46 of the range, where 1.00 is the high Session volume 114,372,980 shares, $228,745,960 Relative volume 853.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
8	SIDU	+163.16%	2023-12-28 against the close of 2023-12-27 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Foundation for the Future: Sidus Space Looks toward 2024 Launch 12/28/2023 08:30 ET premarket	Day +1 +101.60% 2023-12-29 Day +5 +198.40% 2024-01-05 Best close within 5 +198.40% 2024-01-05 Five sessions later the move was 21.6% bigger, at +198.40%. Month end +101.60% on 2023-12-29 This month ended before the fifth session after the move.
Close before and after $4.37 to $11.50 split-adjusted Session open, high, low $4.41, $15.40, $4.41 Opening gap +0.92% Close inside the session range 0.65 of the range, where 1.00 is the high Session volume 18,893,168 shares, $217,271,432 Relative volume 281.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
9	SERA	+161.43%	2023-12-06 against the close of 2023-12-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	SERA PROGNOSTICS ANNOUNCES PRIMARY ENDPOINT CRITERIA MET IN PIVOTAL PRIME STUDY INTERIM LOOK - ENROLLMENT TO STOP DUE TO SUCCESS 12/06/2023 08:30 ET premarket	Day +1 +140.48% 2023-12-07 Day +5 +134.29% 2023-12-13 Best close within 5 +140.48% 2023-12-07 16.8% of the move was gone five sessions later. Month end +184.76% on 2023-12-29
Close before and after $2.10 to $5.49 split-adjusted Session open, high, low $5.01, $9.86, $4.11 Opening gap +138.57% Close inside the session range 0.24 of the range, where 1.00 is the high Session volume 78,807,112 shares, $432,651,045 Relative volume over 1,000x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
10	ATHE Also on the opposite board this month on both boards	+153.01%	2023-12-04 against the close of 2023-12-01 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Alterity Therapeutics Reports Positive Efficacy Data for ATH434 in a Primate Model of Parkinson’s Disease 12/04/2023 07:25 ET premarket	Day +1 +95.18% 2023-12-05 Day +5 +39.16% 2023-12-11 Best close within 5 +95.18% 2023-12-05 74.4% of the move was gone five sessions later. Month end +50.00% on 2023-12-29
Close before and after $1.66 to $4.20 split-adjusted Session open, high, low $4.25, $5.41, $3.55 Opening gap +156.02% Close inside the session range 0.35 of the range, where 1.00 is the high Session volume 34,645,021 shares, $145,509,088 Relative volume over 1,000x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
11	CCCC More than one ranked move this month 2+ ranked moves	+135.47%	2023-12-13 against the close of 2023-12-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	C4 Therapeutics Announces Positive Data from CFT7455 Phase 1 Trial in Relapsed/Refractory Multiple Myeloma 12/12/2023 16:01 ET after hours	Day +1 +114.10% 2023-12-14 Day +5 +85.90% 2023-12-20 Best close within 5 +114.10% 2023-12-14 36.6% of the move was gone five sessions later. Month end +141.45% on 2023-12-29
Close before and after $2.34 to $5.51 split-adjusted Session open, high, low $3.18, $6.03, $3.16 Opening gap +35.90% Close inside the session range 0.82 of the range, where 1.00 is the high Session volume 225,846,272 shares, $1,244,412,959 Relative volume 837.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
12	STTK More than one ranked move this month 2+ ranked moves	+130.33%	2023-12-13 against the close of 2023-12-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Shattuck Labs Announces Positive Initial Topline Data from Ongoing Phase 1 A/B Dose Expansion Clinical Trial of SL-172154 with Azacitidine in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients 12/13/2023 06:00 ET premarket	Day +1 +229.86% 2023-12-14 Day +5 +205.69% 2023-12-20 Best close within 5 +229.86% 2023-12-14 Five sessions later the move was 57.8% bigger, at +205.69%. Month end +237.91% on 2023-12-29
Close before and after $2.11 to $4.86 split-adjusted Session open, high, low $4.38, $5.42, $3.67 Opening gap +107.58% Close inside the session range 0.68 of the range, where 1.00 is the high Session volume 57,197,832 shares, $277,981,464 Relative volume over 1,000x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
13	IVVD	+120.25%	2023-12-18 against the close of 2023-12-15 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Invivyd Announces Positive Initial Results from Ongoing CANOPY Phase 3 Pivotal Clinical Trial Investigating VYD222 for the Prevention of COVID-19 12/18/2023 07:00 ET premarket	Day +1 +103.68% 2023-12-19 Day +5 +123.93% 2023-12-26 Best close within 5 +138.04% 2023-12-22 Five sessions later the move was 3.1% bigger, at +123.93%. Month end +141.72% on 2023-12-29
Close before and after $1.63 to $3.59 split-adjusted Session open, high, low $2.02, $4.71, $2.02 Opening gap +23.93% Close inside the session range 0.58 of the range, where 1.00 is the high Session volume 69,246,691 shares, $248,595,621 Relative volume over 1,000x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
14	RYZB	+100.85%	2023-12-26 against the close of 2023-12-22 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBio 12/26/2023 06:59 ET premarket	Day +1 +101.96% 2023-12-27 Day +5 +102.19% 2024-01-03 Best close within 5 +103.37% 2023-12-29 Five sessions later the move was 1.3% bigger, at +102.19%. Month end +103.37% on 2023-12-29 This month ended before the fifth session after the move.
Close before and after $30.57 to $61.40 as traded Session open, high, low $61.26, $62.10, $61.17 Opening gap +100.39% Close inside the session range 0.25 of the range, where 1.00 is the high Session volume 9,204,538 shares, $565,158,633 Relative volume 40.2x the median of the 20 sessions before the pre-news close Baseline gap 4 calendar days from the pre-news close to the measured session
15	CCCC More than one ranked move this month 2+ ranked moves	+98.31%	2023-12-12 against the close of 2023-12-11 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership	C4 Therapeutics Announces License and Research Collaboration with Merck to Discover and Develop Degrader-Antibody Conjugates (DACs) 12/12/2023 07:00 ET premarket	Day +1 +366.95% 2023-12-13 Day +5 +284.75% 2023-12-19 Best close within 5 +366.95% 2023-12-13 Five sessions later the move was 189.6% bigger, at +284.75%. Month end +378.81% on 2023-12-29
Close before and after $1.18 to $2.34 split-adjusted Session open, high, low $1.82, $2.70, $1.76 Opening gap +54.24% Close inside the session range 0.62 of the range, where 1.00 is the high Session volume 179,486,324 shares, $419,997,998 Relative volume 765.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
16	CYTK	+82.54%	2023-12-27 against the close of 2023-12-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Cytokinetics Announces Positive Results From SEQUOIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy 12/27/2023 07:30 ET premarket Cytokinetics to Host Investor Call on December 27 to Discuss the Topline Results from SEQUOIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Obstructive Hypertrophic Cardiomyopathy 12/26/2023	Day +1 +82.10% 2023-12-28 Day +5 +93.04% 2024-01-04 Best close within 5 +93.04% 2024-01-04 Five sessions later the move was 12.7% bigger, at +93.04%. Month end +82.65% on 2023-12-29 This month ended before the fifth session after the move.
Close before and after $45.71 to $83.44 split-adjusted Session open, high, low $73.65, $83.82, $71.90 Opening gap +61.12% Close inside the session range 0.97 of the range, where 1.00 is the high Session volume 22,099,378 shares, $1,843,972,100 Relative volume 12.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
17	MBI	+81.84%	2023-12-08 against the close of 2023-12-07 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Buyback / Dividend	MBIA Inc. Declares Extraordinary Cash Dividend on MBIA Inc. Common Stock and Dividends from National Public Finance Guarantee Corporation 12/07/2023 16:37 ET after hours	Day +1 +86.99% 2023-12-11 Day +5 +86.72% 2023-12-15 Best close within 5 +92.95% 2023-12-14 Five sessions later the move was 6.0% bigger, at +86.72%. Month end -17.07% on 2023-12-29
Close before and after $7.38 to $13.42 split-adjusted Session open, high, low $12.51, $13.51, $11.77 Opening gap +69.51% Close inside the session range 0.95 of the range, where 1.00 is the high Session volume 11,521,081 shares, $154,612,907 Relative volume 31.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
18	BATL	+81.80%	2023-12-15 against the close of 2023-12-14 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	Battalion Oil Corporation Announces Acquisition By Fury Resources, Inc. 12/15/2023 08:55 ET premarket	Day +1 +81.42% 2023-12-18 Day +5 +82.56% 2023-12-22 Best close within 5 +82.94% 2023-12-21 Five sessions later the move was 0.9% bigger, at +82.56%. Month end +82.18% on 2023-12-29
Close before and after $5.28 to $9.59 split-adjusted Session open, high, low $9.57, $9.68, $9.57 Opening gap +81.42% Close inside the session range 0.18 of the range, where 1.00 is the high Session volume 1,051,911 shares, $10,087,826 Relative volume 57.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
19	SLDB	+68.42%	2023-12-07 against the close of 2023-12-06 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	FDA & Regulatory	Solid Biosciences Receives FDA Fast Track Designation for Duchenne Muscular Dystrophy Gene Therapy SGT-003 12/07/2023 08:00 ET premarket	Day +1 +47.95% 2023-12-08 Day +5 +44.44% 2023-12-14 Best close within 5 +47.95% 2023-12-08 35.0% of the move was gone five sessions later. Month end +79.53% on 2023-12-29
Close before and after $3.42 to $5.76 split-adjusted Session open, high, low $3.59, $6.44, $3.58 Opening gap +4.97% Close inside the session range 0.76 of the range, where 1.00 is the high Session volume 12,300,942 shares, $70,853,426 Relative volume 188.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
20	DSKE	+64.97%	2023-12-22 against the close of 2023-12-21 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	Daseke to be Acquired by TFI International 12/22/2023 09:00 ET premarket	Day +1 +64.77% 2023-12-26 Day +5 +64.77% 2024-01-02 Best close within 5 +65.17% 2023-12-28 0.3% of the move was gone five sessions later. Month end +64.97% on 2023-12-29 This month ended before the fifth session after the move.
Close before and after $4.91 to $8.10 as traded Session open, high, low $7.85, $8.16, $7.85 Opening gap +59.88% Close inside the session range 0.81 of the range, where 1.00 is the high Session volume 4,940,026 shares, $40,014,211 Relative volume 27.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
21	VRCA	+61.97%	2023-12-15 against the close of 2023-12-14 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Verrica Pharmaceuticals’ Development and Commercialization Partner, Torii Pharmaceutical Co., Ltd., Announces Positive Top-line Results from a Confirmatory Phase 3 Trial of TO-208 for the Treatment of Molluscum Contagiosum in Japan 12/15/2023 06:00 ET premarket	Day +1 +47.87% 2023-12-18 Day +5 +81.38% 2023-12-22 Best close within 5 +81.38% 2023-12-22 Five sessions later the move was 31.3% bigger, at +81.38%. Month end +94.68% on 2023-12-29
Close before and after $37.60 to $60.90 split-adjusted Session open, high, low $42.00, $69.20, $40.00 Opening gap +11.70% Close inside the session range 0.72 of the range, where 1.00 is the high Session volume 5,312,963 shares, $323,559,447 Relative volume 596.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
22	GRCL	+60.26%	2023-12-26 against the close of 2023-12-22 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	Gracell Biotechnologies to be acquired by AstraZeneca, furthering cell therapy ambition across oncology and autoimmune diseases 12/26/2023 02:00 ET premarket AstraZeneca to acquire Gracell, furthering cell therapy ambition across oncology and autoimmune diseases 12/26/2023	Day +1 +60.26% 2023-12-27 Day +5 +62.52% 2024-01-03 Best close within 5 +63.17% 2024-01-02 Five sessions later the move was 3.8% bigger, at +62.52%. Month end +62.20% on 2023-12-29 This month ended before the fifth session after the move.
Close before and after $6.19 to $9.92 as traded Session open, high, low $9.91, $9.95, $9.85 Opening gap +60.10% Close inside the session range 0.70 of the range, where 1.00 is the high Session volume 16,122,691 shares, $159,937,095 Relative volume 41.7x the median of the 20 sessions before the pre-news close Baseline gap 4 calendar days from the pre-news close to the measured session
23	MBOT Also on the opposite board this month on both boards	+55.30%	2023-12-28 against the close of 2023-12-27 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were Met 12/28/2023 07:30 ET premarket	Day +1 +24.24% 2023-12-29 Day +5 +4.55% 2024-01-05 Best close within 5 +24.24% 2023-12-29 91.8% of the move was gone five sessions later. Month end +24.24% on 2023-12-29 This month ended before the fifth session after the move.
Close before and after $1.32 to $2.05 split-adjusted Session open, high, low $1.60, $2.23, $1.58 Opening gap +21.21% Close inside the session range 0.72 of the range, where 1.00 is the high Session volume 46,132,007 shares, $94,570,614 Relative volume 834.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
24	ZIMV	+52.41%	2023-12-18 against the close of 2023-12-15 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	ZimVie Announces Definitive Agreement to Sell Spine Business to H.I.G. Capital for $375 Million 12/18/2023 08:00 ET premarket	Day +1 +50.09% 2023-12-19 Day +5 +60.16% 2023-12-26 Best close within 5 +60.61% 2023-12-22 Five sessions later the move was 14.8% bigger, at +60.16%. Month end +58.20% on 2023-12-29
Close before and after $11.22 to $17.10 as traded Session open, high, low $14.24, $17.19, $14.02 Opening gap +26.92% Close inside the session range 0.97 of the range, where 1.00 is the high Session volume 3,519,415 shares, $60,181,997 Relative volume 20.6x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
25	PAPL More than one ranked move this month 2+ ranked moves	+50.68%	2023-12-01 against the close of 2023-11-30 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Pineapple Financial Expands Into Western Canada with New Corporate Office in Metro Vancouver, British Columbia 12/01/2023 08:05 ET premarket	Day +1 +67.81% 2023-12-04 Day +5 +119.18% 2023-12-08 Best close within 5 +146.58% 2023-12-07 Five sessions later the move was 135.2% bigger, at +119.18%. Month end +22.60% on 2023-12-29
Close before and after $1.46 to $2.20 split-adjusted Session open, high, low $1.61, $2.34, $1.44 Opening gap +10.27% Close inside the session range 0.84 of the range, where 1.00 is the high Session volume 4,767,093 shares, $10,487,605 Relative volume 20.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
26	ICVX	+49.48%	2023-12-12 against the close of 2023-12-11 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Icosavax Announces Positive Topline Interim Phase 2 Results for Combination VLP Vaccine Candidate IVX-A12 Against RSV and hMPV in Older Adults 12/12/2023 02:00 ET premarket Icosavax, Inc. Announces Agreement to be Acquired by AstraZeneca 12/12/2023 AstraZeneca to Acquire Icosavax, Including Potential First-in-class RSV and hMPV Combination Vaccine With Positive Phase II Data 12/12/2023	Day +1 +49.95% 2023-12-13 Day +5 +47.47% 2023-12-19 Best close within 5 +49.95% 2023-12-13 4.1% of the move was gone five sessions later. Month end +50.24% on 2023-12-29
Close before and after $10.49 to $15.68 as traded Session open, high, low $15.64, $15.80, $15.30 Opening gap +49.09% Close inside the session range 0.76 of the range, where 1.00 is the high Session volume 9,534,584 shares, $149,502,277 Relative volume 24.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
27	ESOA	+48.86%	2023-12-18 against the close of 2023-12-15 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Energy Services of America Announces Financial Results for the Fiscal Year Ended September 30, 2023 12/18/2023 09:00 ET premarket	Day +1 +54.86% 2023-12-19 Day +5 +61.43% 2023-12-26 Best close within 5 +61.43% 2023-12-26 Five sessions later the move was 25.7% bigger, at +61.43%. Month end +70.86% on 2023-12-29
Close before and after $3.50 to $5.21 split-adjusted Session open, high, low $4.24, $5.50, $4.11 Opening gap +21.14% Close inside the session range 0.79 of the range, where 1.00 is the high Session volume 538,662 shares, $2,806,429 Relative volume 14.1x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
28	KRTX	+47.71%	2023-12-22 against the close of 2023-12-21 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics 12/22/2023 06:59 ET premarket PureTech Founded Entity Karuna Therapeutics to be Acquired by Bristol Myers Squibb for $14 Billion 12/22/2023	Day +1 +47.31% 2023-12-26 Day +5 +46.26% 2024-01-02 Best close within 5 +47.39% 2023-12-27 3.0% of the move was gone five sessions later. Month end +47.08% on 2023-12-29 This month ended before the fifth session after the move.
Close before and after $215.19 to $317.85 as traded Session open, high, low $317.30, $318.75, $315.79 Opening gap +47.45% Close inside the session range 0.70 of the range, where 1.00 is the high Session volume 6,981,441 shares, $2,219,051,022 Relative volume 23.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
29	PUYI	+47.00%	2023-12-27 against the close of 2023-12-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Puyi Announces Share Exchange Transactions with Certain Shareholders of Fanhua 12/27/2023 04:59 ET premarket	Day +1 +62.50% 2023-12-28 Day +5 +41.50% 2024-01-04 Best close within 5 +62.50% 2023-12-28 11.7% of the move was gone five sessions later. Month end +54.25% on 2023-12-29 This month ended before the fifth session after the move.
Close before and after $4.00 to $5.88 as traded Session open, high, low $4.83, $6.08, $4.73 Opening gap +20.75% Close inside the session range 0.85 of the range, where 1.00 is the high Session volume 127,978 shares, $752,511 Relative volume 19.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
30	MRKR	+46.85%	2023-12-11 against the close of 2023-12-08 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Marker Therapeutics Announces Sustained Complete Response in First Lymphoma Patient Treated with MT-601 following CAR T Relapse 12/11/2023 07:00 ET premarket	Day +1 +32.20% 2023-12-12 Day +5 +34.07% 2023-12-18 Best close within 5 +58.08% 2023-12-14 27.3% of the move was gone five sessions later. Month end +71.48% on 2023-12-29
Close before and after $3.21 to $4.71 split-adjusted Session open, high, low $3.31, $4.85, $3.15 Opening gap +3.20% Close inside the session range 0.92 of the range, where 1.00 is the high Session volume 2,674,743 shares, $12,598,040 Relative volume 141.9x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
31	SATL	+45.63%	2023-12-07 against the close of 2023-12-06 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership	Uzma and Satellogic Sign Multi-Million Dollar +3-Year Agreement to Advance Geospatial Capabilities in Southeast Asia 12/07/2023 08:00 ET premarket	Day +1 +43.75% 2023-12-08 Day +5 +19.06% 2023-12-14 Best close within 5 +43.75% 2023-12-08 58.2% of the move was gone five sessions later. Month end +9.37% on 2023-12-29
Close before and after $1.60 to $2.33 split-adjusted Session open, high, low $1.65, $2.52, $1.62 Opening gap +3.12% Close inside the session range 0.79 of the range, where 1.00 is the high Session volume 1,990,183 shares, $4,637,126 Relative volume 44.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
32	BHG	+45.06%	2023-12-29 against the close of 2023-12-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Bright Health Group Strengthens Capital Position with Amendment to its Credit Facility, Impending Close of the Sale of its California Medicare Advantage Business 12/29/2023 06:45 ET premarket	Day +1 +56.84% 2024-01-02 Day +5 +96.20% 2024-01-08 Best close within 5 +123.76% 2024-01-04 Five sessions later the move was 113.5% bigger, at +96.20%. Month end +45.06% on 2023-12-29 same session This month ended before the fifth session after the move.
Close before and after $5.26 to $7.63 as traded Session open, high, low $5.30, $8.50, $5.30 Opening gap +0.76% Close inside the session range 0.73 of the range, where 1.00 is the high Session volume 430,107 shares, $3,281,716 Relative volume 27.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
33	GBNH	+44.82%	2023-12-06 against the close of 2023-12-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	GREENBROOK TMS RAISES US$2.5 MILLION IN DEBT FINANCING 12/05/2023 16:30 ET after hours	Day +1 +35.14% 2023-12-07 Day +5 +30.18% 2023-12-13 Best close within 5 +39.64% 2023-12-08 32.7% of the move was gone five sessions later. Month end +21.85% on 2023-12-29
Close before and after $0.2220 to $0.3215 as traded Session open, high, low $0.3000, $0.3300, $0.2518 Opening gap +35.14% Close inside the session range 0.89 of the range, where 1.00 is the high Session volume 20,075,799 shares, $6,454,369 Relative volume 813.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
34	PAPL More than one ranked move this month 2+ ranked moves	+43.29%	2023-12-06 against the close of 2023-12-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Pineapple Financial Inc. Introduces Simplified Online Mortgage Application for Borrowers 12/06/2023 08:05 ET premarket	Day +1 +55.84% 2023-12-07 Day +5 -16.45% 2023-12-13 Best close within 5 +55.84% 2023-12-07 It gave back the whole move and closed 16.45% below the pre-news price. Month end -22.51% on 2023-12-29
Close before and after $2.31 to $3.31 split-adjusted Session open, high, low $2.31, $3.97, $2.21 Opening gap 0.00% Close inside the session range 0.63 of the range, where 1.00 is the high Session volume 1,375,604 shares, $4,553,249 Relative volume 5.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
35	BETS Also on the opposite board this month on both boards	+43.17%	2023-12-01 against the close of 2023-11-30 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	BETS Announces Purchase of 3300 units of S19 Miners 12/01/2023 09:00 ET premarket	Day +1 +156.09% 2023-12-04 Day +5 -47.23% 2023-12-08 Best close within 5 +156.09% 2023-12-04 It gave back the whole move and closed 47.23% below the pre-news price. Month end -60.52% on 2023-12-29
Close before and after $27.10 to $38.80 as traded Session open, high, low $29.00, $48.00, $25.30 Opening gap +7.01% Close inside the session range 0.59 of the range, where 1.00 is the high Session volume 440,968 shares, $17,109,558 Relative volume 8.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
36	SVFD	+41.86%	2023-12-07 against the close of 2023-12-06 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Save Foods Targeting US Carbon Credit Market with Majority Ownership in Newly- Formed Nitrousink Ltd. 12/07/2023 08:11 ET premarket	Day +1 +36.74% 2023-12-08 Day +5 -6.51% 2023-12-14 Best close within 5 +43.26% 2023-12-11 It gave back the whole move and closed 6.51% below the pre-news price. Month end -6.98% on 2023-12-29
Close before and after $2.15 to $3.05 as traded Session open, high, low $4.09, $7.55, $3.00 Opening gap +90.23% Close inside the session range 0.01 of the range, where 1.00 is the high Session volume 63,949,512 shares, $195,046,012 Relative volume over 1,000x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
37	CDXS	+41.15%	2023-12-14 against the close of 2023-12-13 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership	Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase 12/13/2023 16:06 ET after hours Codexis Announces Achievement of Gram-scale Synthesis with its ECO Synthesis™ Platform 12/13/2023	Day +1 +37.80% 2023-12-15 Day +5 +46.89% 2023-12-21 Best close within 5 +48.33% 2023-12-19 Five sessions later the move was 13.9% bigger, at +46.89%. Month end +45.93% on 2023-12-29
Close before and after $2.09 to $2.95 split-adjusted Session open, high, low $2.30, $3.02, $2.30 Opening gap +10.05% Close inside the session range 0.90 of the range, where 1.00 is the high Session volume 5,957,568 shares, $17,574,826 Relative volume 8.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
38	SEZL	+39.72%	2023-12-22 against the close of 2023-12-21 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Buyback / Dividend	Sezzle Board of Directors Authorizes US$5 Million Stock Repurchase Program 12/22/2023 09:02 ET premarket	Day +1 +9.79% 2023-12-26 Day +5 +22.50% 2024-01-02 Best close within 5 +22.50% 2024-01-02 43.4% of the move was gone five sessions later. Month end +17.46% on 2023-12-29 This month ended before the fifth session after the move.
Close before and after $2.91 to $4.07 split-adjusted Session open, high, low $3.14, $4.58, $2.88 Opening gap +7.73% Close inside the session range 0.70 of the range, where 1.00 is the high Session volume 1,616,886 shares, $6,577,977 Relative volume 9.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
39	IREN	+38.88%	2023-12-21 against the close of 2023-12-20 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	10 EH/s Equity Raising Program Complete 12/21/2023 06:03 ET premarket	Day +1 +51.36% 2023-12-22 Day +5 +29.29% 2023-12-29 Best close within 5 +72.88% 2023-12-27 24.7% of the move was gone five sessions later. Month end +29.29% on 2023-12-29
Close before and after $5.53 to $7.68 split-adjusted Session open, high, low $5.85, $7.73, $5.78 Opening gap +5.79% Close inside the session range 0.97 of the range, where 1.00 is the high Session volume 18,683,304 shares, $143,487,775 Relative volume 4.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
40	ESTC	+37.13%	2023-12-01 against the close of 2023-11-30 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Elastic Reports Second Quarter Fiscal 2024 Financial Results 11/30/2023 16:05 ET after hours Elastic Completes Acquisition of Opster 11/30/2023	Day +1 +37.52% 2023-12-04 Day +5 +44.11% 2023-12-08 Best close within 5 +44.11% 2023-12-08 Five sessions later the move was 18.8% bigger, at +44.11%. Month end +40.24% on 2023-12-29
Close before and after $80.36 to $110.20 split-adjusted Session open, high, low $98.24, $111.75, $97.78 Opening gap +22.25% Close inside the session range 0.89 of the range, where 1.00 is the high Session volume 12,243,764 shares, $1,349,262,793 Relative volume 12.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
41	IPSC	+36.08%	2023-12-06 against the close of 2023-12-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	FDA & Regulatory	Century Therapeutics Receives FDA Clearance of IND Application for CNTY-101 in Systemic Lupus Erythematosus 12/06/2023 07:30 ET premarket Century Therapeutics to Host Conference Call to Discuss Preliminary Clinical Data from Phase 1 ELiPSE-1 trial of CNTY-101 in Relapsed or Refractory B-cell Lymphomas and Planned Phase 1 Study in Systemic Lupus Erythematosus 12/06/2023	Day +1 +47.47% 2023-12-07 Day +5 +68.35% 2023-12-13 Best close within 5 +68.35% 2023-12-13 Five sessions later the move was 89.4% bigger, at +68.35%. Month end +110.13% on 2023-12-29
Close before and after $1.58 to $2.15 split-adjusted Session open, high, low $1.71, $2.29, $1.60 Opening gap +8.23% Close inside the session range 0.80 of the range, where 1.00 is the high Session volume 1,145,741 shares, $2,463,343 Relative volume 8.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
42	ARBK	+35.48%	2023-12-04 against the close of 2023-12-01 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Crypto & Treasury	Argo Blockchain PLC Announces November Monthly Operational Update 12/04/2023 02:00 ET premarket	Day +1 +36.29% 2023-12-05 Day +5 +27.42% 2023-12-11 Best close within 5 +50.00% 2023-12-08 22.7% of the move was gone five sessions later. Month end +201.61% on 2023-12-29
Close before and after $267.84 to $362.88 split-adjusted Session open, high, low $313.20, $362.88, $287.28 Opening gap +16.94% Close inside the session range 1.00 of the range, where 1.00 is the high Session volume 5,568 shares, $2,020,516 Relative volume 6.7x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
43	CVM	+35.27%	2023-12-04 against the close of 2023-12-01 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	UK’S National Institute for Health and Care Excellence (NICE) Selects CEL-SCI’s Multikine as Potential New Standard of Care for Head & Neck Cancer 12/04/2023 08:30 ET premarket	Day +1 +37.68% 2023-12-05 Day +5 +30.92% 2023-12-11 Best close within 5 +37.68% 2023-12-05 12.3% of the move was gone five sessions later. Month end +31.40% on 2023-12-29
Close before and after $62.10 to $84.00 split-adjusted Session open, high, low $64.50, $88.20, $64.20 Opening gap +3.86% Close inside the session range 0.82 of the range, where 1.00 is the high Session volume 96,491 shares, $8,105,244 Relative volume 3.8x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
44	VGZ	+35.14%	2023-12-14 against the close of 2023-12-13 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Vista Gold Corp. Announces $20 Million Royalty with Wheaton Precious Metals Corp. on Mt Todd 12/14/2023 06:40 ET premarket	Day +1 +29.13% 2023-12-15 Day +5 +32.82% 2023-12-21 Best close within 5 +35.14% 2023-12-19 6.6% of the move was gone five sessions later. Month end +35.71% on 2023-12-29
Close before and after $0.3330 to $0.4500 split-adjusted Session open, high, low $0.3350, $0.4599, $0.3350 Opening gap +0.60% Close inside the session range 0.92 of the range, where 1.00 is the high Session volume 1,713,700 shares, $771,165 Relative volume 5.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
45	ACAD	+34.48%	2023-12-13 against the close of 2023-12-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Delaware Federal District Court Rules in Favor of Acadia Pharmaceuticals in NUPLAZID® (pimavanserin) Patent Litigation 12/13/2023 13:41 ET intraday	Day +1 +32.55% 2023-12-14 Day +5 +37.22% 2023-12-20 Best close within 5 +42.32% 2023-12-19 Five sessions later the move was 7.9% bigger, at +37.22%. Month end +47.90% on 2023-12-29
Close before and after $21.17 to $28.47 split-adjusted Session open, high, low $21.50, $28.94, $21.41 Opening gap +1.56% Close inside the session range 0.94 of the range, where 1.00 is the high Session volume 14,153,458 shares, $402,948,949 Relative volume 12.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
46	PRTC	+33.93%	2023-12-22 against the close of 2023-12-21 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	PureTech Founded Entity Karuna Therapeutics to be Acquired by Bristol Myers Squibb for $14 Billion 12/22/2023 09:13 ET premarket	Day +1 +31.88% 2023-12-26 Day +5 +31.30% 2024-01-02 Best close within 5 +48.00% 2023-12-29 7.8% of the move was gone five sessions later. Month end +48.00% on 2023-12-29 This month ended before the fifth session after the move.
Close before and after $19.04 to $25.50 as traded Session open, high, low $20.84, $25.50, $20.84 Opening gap +9.45% Close inside the session range 1.00 of the range, where 1.00 is the high Session volume 8,063 shares, $205,607 Relative volume 9.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
47	CONN	+33.68%	2023-12-19 against the close of 2023-12-18 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings catalyst from a later release the same session	Conn’s, Inc. Announces Transformative Transaction with W.S. Badcock LLC 12/18/2023 17:13 ET after hours Conn’s, Inc. Reports Third Quarter Fiscal Year 2024 Financial Results 12/18/2023	Day +1 +25.26% 2023-12-20 Day +5 +52.63% 2023-12-27 Best close within 5 +52.63% 2023-12-27 Five sessions later the move was 56.3% bigger, at +52.63%. Month end +55.79% on 2023-12-29
Close before and after $2.85 to $3.81 as traded Session open, high, low $2.99, $3.88, $2.84 Opening gap +4.91% Close inside the session range 0.93 of the range, where 1.00 is the high Session volume 1,545,715 shares, $5,889,174 Relative volume 26.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
48	MFH	+33.05%	2023-12-05 against the close of 2023-12-04 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution Rose on dilution	Mercurity Fintech Holding Inc. Announces $6 Million Private Placement Financing 12/04/2023 16:05 ET after hours	Day +1 +48.31% 2023-12-06 Day +5 +40.68% 2023-12-12 Best close within 5 +50.85% 2023-12-08 Five sessions later the move was 23.1% bigger, at +40.68%. Month end +120.34% on 2023-12-29
Close before and after $1.18 to $1.57 as traded Session open, high, low $1.24, $1.85, $1.18 Opening gap +5.08% Close inside the session range 0.58 of the range, where 1.00 is the high Session volume 6,510,606 shares, $10,221,651 Relative volume over 1,000x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
49	CCLD Also on the opposite board this month on both boards	+32.93%	2023-12-20 against the close of 2023-12-19 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	CareCloud Financial & Operational Update 12/20/2023 09:00 ET premarket	Day +1 +69.51% 2023-12-21 Day +5 +102.44% 2023-12-28 Best close within 5 +119.51% 2023-12-26 Five sessions later the move was 211.1% bigger, at +102.44%. Month end +85.37% on 2023-12-29
Close before and after $0.8200 to $1.09 split-adjusted Session open, high, low $0.8200, $1.09, $0.8101 Opening gap 0.00% Close inside the session range 1.00 of the range, where 1.00 is the high Session volume 362,432 shares, $395,051 Relative volume 9.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
50	TGI	+32.93%	2023-12-21 against the close of 2023-12-20 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	TRIUMPH ANNOUNCES SALE OF PRODUCT SUPPORT BUSINESS TO AAR 12/21/2023 08:00 ET premarket AAR announces agreement to acquire Triumph Group's Product Support business, a leading provider of MRO services to the global aviation aftermarket 12/21/2023	Day +1 +37.33% 2023-12-22 Day +5 +35.13% 2023-12-29 Best close within 5 +38.14% 2023-12-28 Five sessions later the move was 6.7% bigger, at +35.13%. Month end +35.13% on 2023-12-29
Close before and after $12.27 to $16.31 as traded Session open, high, low $13.82, $16.46, $13.82 Opening gap +12.63% Close inside the session range 0.94 of the range, where 1.00 is the high Session volume 5,091,351 shares, $83,039,935 Relative volume 6.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
51	SRFM	+32.76%	2023-12-28 against the close of 2023-12-27 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Surf Air Mobility Enters into Binding Terms for a $35.2 Million Mandatory Convertible Debenture with GEM Global Yield LLC 12/28/2023 08:30 ET premarket	Day +1 +33.62% 2023-12-29 Day +5 0.00% 2024-01-05 Best close within 5 +33.62% 2023-12-29 100.0% of the move was gone five sessions later. Month end +33.62% on 2023-12-29 This month ended before the fifth session after the move.
Close before and after $8.12 to $10.78 split-adjusted Session open, high, low $7.91, $11.83, $7.70 Opening gap -2.59% Close inside the session range 0.75 of the range, where 1.00 is the high Session volume 98,008 shares, $1,056,526 Relative volume 3.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
52	MGTX	+32.59%	2023-12-21 against the close of 2023-12-20 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership	MeiraGTx Announces Asset Purchase Agreement Involving its AAV-RPGR Collaboration for up to $415 million 12/21/2023 07:00 ET premarket	Day +1 +43.99% 2023-12-22 Day +5 +42.97% 2023-12-29 Best close within 5 +45.62% 2023-12-26 Five sessions later the move was 31.9% bigger, at +42.97%. Month end +42.97% on 2023-12-29
Close before and after $4.91 to $6.51 split-adjusted Session open, high, low $5.82, $6.59, $5.71 Opening gap +18.53% Close inside the session range 0.91 of the range, where 1.00 is the high Session volume 2,420,661 shares, $15,758,503 Relative volume 9.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
53	EOSE Also on the opposite board this month on both boards	+32.14%	2023-12-13 against the close of 2023-12-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership	Eos Energy and Pine Gate Renewables Announce Partnership Expansion 12/12/2023 16:30 ET after hours	Day +1 +50.00% 2023-12-14 Day +5 -1.79% 2023-12-20 Best close within 5 +50.00% 2023-12-14 It gave back the whole move and closed 1.79% below the pre-news price. Month end -2.68% on 2023-12-29
Close before and after $1.12 to $1.48 split-adjusted Session open, high, low $1.18, $1.53, $1.15 Opening gap +5.36% Close inside the session range 0.87 of the range, where 1.00 is the high Session volume 16,782,602 shares, $24,838,251 Relative volume 3.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
54	SDIG	+31.00%	2023-12-22 against the close of 2023-12-21 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution Rose on dilution	Stronghold Enters Into $15 Million Private Placement 12/22/2023 08:30 ET premarket	Day +1 +40.83% 2023-12-26 Day +5 -1.64% 2024-01-02 Best close within 5 +68.55% 2023-12-27 It gave back the whole move and closed 1.64% below the pre-news price. Month end +8.79% on 2023-12-29 This month ended before the fifth session after the move.
Close before and after $6.71 to $8.79 as traded Session open, high, low $6.92, $9.28, $6.55 Opening gap +3.13% Close inside the session range 0.82 of the range, where 1.00 is the high Session volume 4,491,453 shares, $39,479,872 Relative volume 7.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
55	ARVN	+30.77%	2023-12-06 against the close of 2023-12-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Arvinas to Host Conference Call and Webcast to Discuss Vepdegestrant (ARV-471) Data Presented at 2023 San Antonio Breast Cancer Symposium and Plans to Expand Vepdegestrant Development Program 12/05/2023 22:52 ET after hours	Day +1 +41.09% 2023-12-07 Day +5 +46.61% 2023-12-13 Best close within 5 +47.43% 2023-12-08 Five sessions later the move was 51.5% bigger, at +46.61%. Month end +77.64% on 2023-12-29
Close before and after $23.17 to $30.30 split-adjusted Session open, high, low $24.41, $30.99, $24.11 Opening gap +5.35% Close inside the session range 0.90 of the range, where 1.00 is the high Session volume 2,863,245 shares, $86,756,324 Relative volume 4.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
56	ANNX	+29.51%	2023-12-21 against the close of 2023-12-20 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Annexon Reports Phase 1 Results for ANX1502, its Oral Small Molecule Inhibitor of the Classical Complement Pathway 12/20/2023 17:08 ET after hours Annexon Outlines Global Registrational Program for ANX007 in Geographic Atrophy with FDA Alignment on Vision Preservation as Primary Endpoint 12/20/2023 Annexon Announces Pricing of $125.0 Million Underwritten Public Offering of Common Stock 12/20/2023	Day +1 +39.24% 2023-12-22 Day +5 +57.64% 2023-12-29 Best close within 5 +60.76% 2023-12-27 Five sessions later the move was 95.3% bigger, at +57.64%. Month end +57.64% on 2023-12-29
Close before and after $2.88 to $3.73 split-adjusted Session open, high, low $3.60, $4.04, $3.27 Opening gap +25.00% Close inside the session range 0.60 of the range, where 1.00 is the high Session volume 13,565,106 shares, $50,597,845 Relative volume 52.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
57	KEQU	+29.27%	2023-12-07 against the close of 2023-12-06 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2024 12/06/2023 16:46 ET after hours	Day +1 +25.36% 2023-12-08 Day +5 +32.44% 2023-12-14 Best close within 5 +32.44% 2023-12-14 Five sessions later the move was 10.8% bigger, at +32.44%. Month end +64.89% on 2023-12-29
Close before and after $17.63 to $22.79 split-adjusted Session open, high, low $21.00, $24.00, $21.00 Opening gap +19.12% Close inside the session range 0.60 of the range, where 1.00 is the high Session volume 25,193 shares, $574,148 Relative volume 28.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
58	DMK	+28.73%	2023-12-21 against the close of 2023-12-20 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	DMK Pharmaceuticals Regains Full Rights to Commercialize ZIMHI 12/21/2023 08:15 ET premarket	Day +1 +27.03% 2023-12-22 Day +5 +18.61% 2023-12-29 Best close within 5 +30.40% 2023-12-26 35.2% of the move was gone five sessions later. Month end +18.61% on 2023-12-29
Close before and after $0.5904 to $0.7600 as traded Session open, high, low $0.9200, $1.04, $0.6611 Opening gap +55.83% Close inside the session range 0.26 of the range, where 1.00 is the high Session volume 32,347,206 shares, $24,583,877 Relative volume 407.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
59	RMCO	+28.64%	2023-12-22 against the close of 2023-12-21 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Royalty Management Holding Corporation's Portfolio Company, Ferrox Holdings Ltd, Commences Production from its Tivani Project 12/22/2023 08:15 ET premarket	Day +1 +17.59% 2023-12-26 Day +5 -15.08% 2024-01-02 Best close within 5 +17.59% 2023-12-26 It gave back the whole move and closed 15.08% below the pre-news price. Month end -14.57% on 2023-12-29 This month ended before the fifth session after the move.
Close before and after $1.99 to $2.56 split-adjusted Session open, high, low $4.39, $4.75, $2.49 Opening gap +120.60% Close inside the session range 0.03 of the range, where 1.00 is the high Session volume 37,833,598 shares, $96,854,011 Relative volume 929.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
60	GNS	+28.31%	2023-12-15 against the close of 2023-12-14 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Genius Group Provides Updated Guidance, with Profitable 2023 on 43% to 60% Revenue Growth. 12/15/2023 07:00 ET premarket	Day +1 +22.05% 2023-12-18 Day +5 +21.19% 2023-12-22 Best close within 5 +35.59% 2023-12-20 25.2% of the move was gone five sessions later. Month end +12.36% on 2023-12-29
Close before and after $5.90 to $7.57 split-adjusted Session open, high, low $6.80, $7.80, $6.50 Opening gap +15.25% Close inside the session range 0.82 of the range, where 1.00 is the high Session volume 1,365,365 shares, $10,335,813 Relative volume 11.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
61	NCSM	+28.31%	2023-12-15 against the close of 2023-12-14 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	NCS Multistage Holdings, Inc. Settles Outstanding Commercial Litigation with No Cash Payment By Company 12/14/2023 16:05 ET after hours	Day +1 +27.88% 2023-12-18 Day +5 +21.52% 2023-12-22 Best close within 5 +27.88% 2023-12-18 24.0% of the move was gone five sessions later. Month-end is not shown: no closing price is available for 2023-12-29.
Close before and after $13.99 to $17.95 split-adjusted Session open, high, low $18.79, $18.85, $17.60 Opening gap +34.31% Close inside the session range 0.28 of the range, where 1.00 is the high Session volume 46,469 shares, $834,119 Relative volume 14.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
62	PATH	+26.72%	2023-12-01 against the close of 2023-11-30 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	UiPath Reports Third Quarter Fiscal 2024 Financial Results 11/30/2023 16:10 ET after hours	Day +1 +27.78% 2023-12-04 Day +5 +24.65% 2023-12-08 Best close within 5 +27.78% 2023-12-04 7.7% of the move was gone five sessions later. Month end +25.71% on 2023-12-29
Close before and after $19.76 to $25.04 split-adjusted Session open, high, low $22.61, $25.47, $22.13 Opening gap +14.42% Close inside the session range 0.87 of the range, where 1.00 is the high Session volume 53,677,044 shares, $1,344,073,182 Relative volume 9.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
63	JG Also on the opposite board this month on both boards	+26.53%	2023-12-12 against the close of 2023-12-11 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	MoonFox Data: JD.com Q3 profits exceeded expectations and the "low prices & supply chain" combo approach showed initial effectiveness 12/12/2023 02:20 ET premarket	Day +1 +4.08% 2023-12-13 Day +5 0.00% 2023-12-19 Best close within 5 +4.08% 2023-12-13 100.0% of the move was gone five sessions later. Month end +45.51% on 2023-12-29
Close before and after $1.96 to $2.48 split-adjusted Session open, high, low $1.91, $2.55, $1.86 Opening gap -2.55% Close inside the session range 0.90 of the range, where 1.00 is the high Session volume 322,384 shares, $799,512 Relative volume 26.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
64	X	+26.09%	2023-12-18 against the close of 2023-12-15 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	Nippon Steel Corporation (NSC) to Acquire U. S. Steel, Moving Forward Together as the ‘Best Steelmaker with World-Leading Capabilities’ 12/18/2023 06:00 ET premarket	Day +1 +23.01% 2023-12-19 Day +5 +22.93% 2023-12-26 Best close within 5 +23.01% 2023-12-19 12.1% of the move was gone five sessions later. Month end +23.70% on 2023-12-29
Close before and after $39.33 to $49.59 as traded Session open, high, low $49.77, $50.20, $49.24 Opening gap +26.54% Close inside the session range 0.36 of the range, where 1.00 is the high Session volume 70,267,384 shares, $3,484,559,573 Relative volume 18.5x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
65	ASR	+26.06%	2023-12-14 against the close of 2023-12-13 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	ASUR Announces Approval of its 2024-2028 Investment Plan Totaling Ps.28.5 billion Expressed in Currency as of December 2022 12/13/2023 16:30 ET after hours	Day +1 +28.38% 2023-12-15 Day +5 +29.99% 2023-12-21 Best close within 5 +29.99% 2023-12-21 Five sessions later the move was 15.1% bigger, at +29.99%. Month end +28.11% on 2023-12-29
Close before and after $229.70 to $289.56 split-adjusted Session open, high, low $239.28, $290.79, $239.28 Opening gap +4.17% Close inside the session range 0.98 of the range, where 1.00 is the high Session volume 204,080 shares, $59,093,405 Relative volume 5.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
66	GAU	+25.84%	2023-12-21 against the close of 2023-12-20 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	GALIANO GOLD CONSOLIDATES OWNERSHIP OF THE ASANKO GOLD MINE IN TRANSFORMATIONAL TRANSACTION 12/21/2023 07:30 ET premarket	Day +1 +30.85% 2023-12-22 Day +5 +42.84% 2023-12-29 Best close within 5 +48.31% 2023-12-27 Five sessions later the move was 65.8% bigger, at +42.84%. Month end +42.84% on 2023-12-29
Close before and after $0.6580 to $0.8280 split-adjusted Session open, high, low $0.6700, $0.8500, $0.6700 Opening gap +1.82% Close inside the session range 0.88 of the range, where 1.00 is the high Session volume 4,277,071 shares, $3,541,415 Relative volume 26.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
67	IOT release reads negative	+25.60%	2023-12-01 against the close of 2023-11-30 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings Release reads negative, stock rose 25.60%	Samsara Reports Third Quarter Fiscal Year 2024 Financial Results 11/30/2023 16:10 ET after hours City of New Orleans Chooses Samsara’s Connected Operations Cloud Across 41 Departments 11/30/2023	Day +1 +24.55% 2023-12-04 Day +5 +22.26% 2023-12-08 Best close within 5 +25.89% 2023-12-05 13.0% of the move was gone five sessions later. Month end +21.21% on 2023-12-29
Close before and after $27.54 to $34.59 split-adjusted Session open, high, low $31.00, $34.74, $29.63 Opening gap +12.56% Close inside the session range 0.97 of the range, where 1.00 is the high Session volume 16,766,615 shares, $579,957,213 Relative volume 7.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
68	GKOS	+25.36%	2023-12-14 against the close of 2023-12-13 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	FDA & Regulatory	Glaukos Announces FDA Approval of iDose® TR (travoprost intracameral implant) 12/14/2023 07:00 ET premarket	Day +1 +34.86% 2023-12-15 Day +5 +40.86% 2023-12-21 Best close within 5 +40.86% 2023-12-21 Five sessions later the move was 61.1% bigger, at +40.86%. Month end +31.56% on 2023-12-29
Close before and after $60.42 to $75.74 split-adjusted Session open, high, low $65.00, $77.44, $65.00 Opening gap +7.58% Close inside the session range 0.86 of the range, where 1.00 is the high Session volume 3,434,344 shares, $260,117,215 Relative volume 7.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
69	RNXT	+25.35%	2023-12-13 against the close of 2023-12-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	RenovoRx Files New International Patent for Novel Targeted Combination Drug-Delivery Oncology Therapy Platform 12/13/2023 08:31 ET premarket	Day +1 +51.43% 2023-12-14 Day +5 +11.81% 2023-12-20 Best close within 5 +51.43% 2023-12-14 53.4% of the move was gone five sessions later. Month end +260.63% on 2023-12-29
Close before and after $0.6350 to $0.7960 split-adjusted Session open, high, low $0.6500, $0.8700, $0.6500 Opening gap +2.36% Close inside the session range 0.66 of the range, where 1.00 is the high Session volume 479,208 shares, $381,450 Relative volume 19.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
70	MOR	+25.25%	2023-12-11 against the close of 2023-12-08 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	MorphoSys’ Pelabresib Improves All Four Hallmarks of Myelofibrosis in Phase 3 MANIFEST-2 Study 12/10/2023 19:31 ET after hours	Day +1 +35.18% 2023-12-12 Day +5 +36.88% 2023-12-18 Best close within 5 +37.87% 2023-12-15 Five sessions later the move was 46.1% bigger, at +36.88%. Month end +40.43% on 2023-12-29
Close before and after $7.05 to $8.83 as traded Session open, high, low $7.70, $9.24, $7.61 Opening gap +9.22% Close inside the session range 0.75 of the range, where 1.00 is the high Session volume 4,541,506 shares, $40,101,498 Relative volume 3.5x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
71	BVN	+25.13%	2023-12-15 against the close of 2023-12-14 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	Buenaventura Comments on Acquisition of Equity Interest in Buenaventura by Antofagasta plc 12/15/2023 12:03 ET intraday	Day +1 +31.13% 2023-12-18 Day +5 +51.25% 2023-12-22 Best close within 5 +51.25% 2023-12-22 Five sessions later the move was 103.9% bigger, at +51.25%. Month end +52.55% on 2023-12-29
Close before and after $9.99 to $12.50 split-adjusted Session open, high, low $10.13, $12.73, $10.13 Opening gap +1.40% Close inside the session range 0.91 of the range, where 1.00 is the high Session volume 20,400,606 shares, $255,007,575 Relative volume 15.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
72	ONTX	+25.10%	2023-12-11 against the close of 2023-12-08 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Onconova Therapeutics’ Preclinical Narazaciclib Data at SABCS Highlights Differentiated Anti-Tumor Activity v. Other CDK4/6i’s 12/08/2023 16:05 ET after hours	Day +1 +11.80% 2023-12-12 Day +5 +19.24% 2023-12-18 Best close within 5 +24.53% 2023-12-13 23.3% of the move was gone five sessions later. Month end +18.07% on 2023-12-29
Close before and after $0.6315 to $0.7900 split-adjusted Session open, high, low $0.7184, $0.8300, $0.6700 Opening gap +13.76% Close inside the session range 0.75 of the range, where 1.00 is the high Session volume 5,665,692 shares, $4,475,897 Relative volume 122.9x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
73	PAVM	+24.84%	2023-12-12 against the close of 2023-12-11 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Results from Three Clinical Utility Studies 12/12/2023 08:30 ET premarket	Day +1 +19.03% 2023-12-13 Day +5 +27.74% 2023-12-19 Best close within 5 +27.74% 2023-12-19 Five sessions later the move was 11.7% bigger, at +27.74%. Month end +32.90% on 2023-12-29
Close before and after $93.00 to $116.10 split-adjusted Session open, high, low $93.00, $123.60, $91.50 Opening gap 0.00% Close inside the session range 0.77 of the range, where 1.00 is the high Session volume 10,420 shares, $1,209,762 Relative volume 9.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
74	PRCH	+24.70%	2023-12-06 against the close of 2023-12-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership	Porch Group Announces New Warranty Partnerships and Products 12/05/2023 16:42 ET after hours	Day +1 +29.52% 2023-12-07 Day +5 +43.98% 2023-12-13 Best close within 5 +43.98% 2023-12-13 Five sessions later the move was 78.1% bigger, at +43.98%. Month end +85.54% on 2023-12-29
Close before and after $1.66 to $2.07 split-adjusted Session open, high, low $1.66, $2.10, $1.66 Opening gap 0.00% Close inside the session range 0.93 of the range, where 1.00 is the high Session volume 4,465,040 shares, $9,242,633 Relative volume 2.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
75	IPWR	+24.61%	2023-12-18 against the close of 2023-12-15 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Stellantis Named Ideal Power Finalist in 2023 Stellantis Venture Awards 12/18/2023 09:20 ET premarket	Day +1 +15.85% 2023-12-19 Day +5 +7.93% 2023-12-26 Best close within 5 +15.85% 2023-12-19 67.8% of the move was gone five sessions later. Month end +0.13% on 2023-12-29
Close before and after $7.76 to $9.67 split-adjusted Session open, high, low $8.08, $9.81, $7.99 Opening gap +4.12% Close inside the session range 0.92 of the range, where 1.00 is the high Session volume 50,290 shares, $486,304 Relative volume 6.2x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
76	BYTS Also on the opposite board this month on both boards	+24.34%	2023-12-18 against the close of 2023-12-15 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Reverse Merger / Shell	BYTE Acquisition Corp. Announces Adjournment of Shareholder Meeting to Approve Business Combination with Airship AI 12/15/2023 18:20 ET after hours	Day +1 +29.59% 2023-12-19 Day +5 no data Best close within 5 +31.08% 2023-12-20 Month-end is not shown: no closing price is available for 2023-12-29.
Close before and after $8.01 to $9.96 as traded Session open, high, low $7.48, $10.50, $7.48 Opening gap -6.62% Close inside the session range 0.82 of the range, where 1.00 is the high Session volume 78,640 shares, $783,254 Relative volume 115.1x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
77	CVRX	+24.21%	2023-12-26 against the close of 2023-12-22 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	FDA & Regulatory	CVRx receives FDA approval for expanded labeling of Barostim 12/26/2023 08:05 ET premarket	Day +1 +23.05% 2023-12-27 Day +5 +18.25% 2024-01-03 Best close within 5 +32.09% 2023-12-28 24.6% of the move was gone five sessions later. Month end +25.81% on 2023-12-29 This month ended before the fifth session after the move.
Close before and after $24.99 to $31.04 split-adjusted Session open, high, low $25.00, $31.18, $25.00 Opening gap +0.04% Close inside the session range 0.98 of the range, where 1.00 is the high Session volume 641,154 shares, $19,901,420 Relative volume 4.9x the median of the 20 sessions before the pre-news close Baseline gap 4 calendar days from the pre-news close to the measured session
78	NRXP	+24.19%	2023-12-18 against the close of 2023-12-15 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	FDA & Regulatory	NRx Pharmaceuticals Announces FDA Clearance of its Investigational New Drug (IND) Application for NRX-101 in the Treatment of Complicated Urinary Tract Infections 12/18/2023 06:48 ET premarket	Day +1 +15.07% 2023-12-19 Day +5 +37.76% 2023-12-26 Best close within 5 +37.76% 2023-12-26 Five sessions later the move was 56.1% bigger, at +37.76%. Month end +35.69% on 2023-12-29
Close before and after $3.39 to $4.21 split-adjusted Session open, high, low $4.39, $4.77, $3.70 Opening gap +29.38% Close inside the session range 0.48 of the range, where 1.00 is the high Session volume 2,471,751 shares, $10,406,072 Relative volume 110.9x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
79	AAOI	+24.15%	2023-12-01 against the close of 2023-11-30 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution Rose on dilution	Applied Optoelectronics Announces Pricing of $80.2 million of Convertible Senior Notes due 2026 12/01/2023 08:00 ET premarket	Day +1 +25.89% 2023-12-04 Day +5 +49.13% 2023-12-08 Best close within 5 +49.13% 2023-12-08 Five sessions later the move was 103.4% bigger, at +49.13%. Month end +45.81% on 2023-12-29
Close before and after $13.25 to $16.45 split-adjusted Session open, high, low $13.19, $16.48, $12.98 Opening gap -0.45% Close inside the session range 0.99 of the range, where 1.00 is the high Session volume 5,624,683 shares, $92,526,035 Relative volume 2.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
80	VLCN	+23.75%	2023-12-22 against the close of 2023-12-21 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Volcon Stag Manufacturing Update December 2023 12/22/2023 09:27 ET premarket	Day +1 +75.00% 2023-12-26 Day +5 +21.25% 2024-01-02 Best close within 5 +75.00% 2023-12-26 10.5% of the move was gone five sessions later. Month end +23.87% on 2023-12-29 This month ended before the fifth session after the move.
Close before and after $23,040.00 to $28,512.00 as traded Session open, high, low $22,464.00, $31,017.60, $21,628.80 Opening gap -2.50% Close inside the session range 0.73 of the range, where 1.00 is the high Session volume 129 shares, $3,678,048 Relative volume 8.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
81	CHRS	+23.39%	2023-12-27 against the close of 2023-12-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	FDA & Regulatory	Coherus Announces FDA Approval of UDENYCA ONBODY™, a Novel and Proprietary State-of-the-Art Delivery System for pegfilgrastim-cbqv 12/26/2023 16:01 ET after hours	Day +1 +48.62% 2023-12-28 Day +5 +33.94% 2024-01-04 Best close within 5 +52.75% 2023-12-29 Five sessions later the move was 45.1% bigger, at +33.94%. Month end +52.75% on 2023-12-29 This month ended before the fifth session after the move.
Close before and after $2.18 to $2.69 split-adjusted Session open, high, low $3.00, $3.05, $2.56 Opening gap +37.61% Close inside the session range 0.27 of the range, where 1.00 is the high Session volume 54,465,764 shares, $146,512,905 Relative volume 18.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
82	ENLV	+22.96%	2023-12-20 against the close of 2023-12-19 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Enlivex Announces Completion of Enrollment of Its Phase II Trial Evaluating Allocetra In Patients With Sepsis 12/20/2023 08:00 ET premarket	Day +1 +43.40% 2023-12-21 Day +5 +62.26% 2023-12-28 Best close within 5 +83.65% 2023-12-22 Five sessions later the move was 171.2% bigger, at +62.26%. Month end +69.81% on 2023-12-29
Close before and after $23.85 to $29.33 split-adjusted Session open, high, low $24.45, $34.50, $24.45 Opening gap +2.52% Close inside the session range 0.49 of the range, where 1.00 is the high Session volume 27,394 shares, $803,329 Relative volume 21.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
83	TNXP Also on the opposite board this month on both boards	+22.74%	2023-12-14 against the close of 2023-12-13 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Hope On The Horizon: Tonix Pharmaceuticals (NASDAQ:TNXP) Could Be On the Cusp of Changing Fibromyalgia Treatment Options With TNX-102 SL 12/14/2023 09:15 ET premarket	Day +1 +37.62% 2023-12-15 Day +5 -8.59% 2023-12-21 Best close within 5 +60.05% 2023-12-18 It gave back the whole move and closed 8.59% below the pre-news price. Month end -3.01% on 2023-12-29
Close before and after $1,329.60 to $1,632.00 split-adjusted Session open, high, low $1,347.52, $1,696.00, $1,347.52 Opening gap +1.35% Close inside the session range 0.82 of the range, where 1.00 is the high Session volume 691 shares, $1,127,712 Relative volume 3.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
84	STTK More than one ranked move this month 2+ ranked moves	+22.56%	2023-12-06 against the close of 2023-12-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Shattuck Labs to Host Investor Call and Webcast to Share Initial Clinical Trial Data from Phase 1A/B Dose-Expansion Cohorts in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53m Acute Myeloid Leukemia (AML) and Review of Dose-Escalation Data from the American Society of Hematology (ASH) 2023 Annual Meeting on December 13, 2023 12/05/2023 16:15 ET after hours	Day +1 +21.03% 2023-12-07 Day +5 +149.23% 2023-12-13 Best close within 5 +149.23% 2023-12-13 Five sessions later the move was 561.5% bigger, at +149.23%. Month end +265.64% on 2023-12-29
Close before and after $1.95 to $2.39 split-adjusted Session open, high, low $1.99, $2.39, $1.96 Opening gap +2.05% Close inside the session range 1.00 of the range, where 1.00 is the high Session volume 40,478 shares, $96,742 Relative volume 1.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
85	DOYU	+22.47%	2023-12-28 against the close of 2023-12-27 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Buyback / Dividend	DouYu International Holdings Limited Announces Share Repurchase Program 12/28/2023 06:30 ET premarket	Day +1 +30.49% 2023-12-29 Day +5 +25.66% 2024-01-05 Best close within 5 +30.49% 2023-12-29 Five sessions later the move was 14.2% bigger, at +25.66%. Month end +30.49% on 2023-12-29 This month ended before the fifth session after the move.
Close before and after $7.28 to $8.92 split-adjusted Session open, high, low $7.77, $9.10, $7.72 Opening gap +6.73% Close inside the session range 0.87 of the range, where 1.00 is the high Session volume 526,934 shares, $4,698,144 Relative volume 6.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
86	CLSK	+22.44%	2023-12-01 against the close of 2023-11-30 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	CleanSpark Reports Fiscal Year 2023 Financial Results 11/30/2023 16:01 ET after hours CleanSpark Releases November 2023 Bitcoin Mining Update 12/01/2023	Day +1 +42.15% 2023-12-04 Day +5 +65.71% 2023-12-08 Best close within 5 +65.71% 2023-12-08 Five sessions later the move was 192.8% bigger, at +65.71%. Month end +76.76% on 2023-12-29
Close before and after $6.24 to $7.64 split-adjusted Session open, high, low $5.91, $7.79, $5.73 Opening gap -5.29% Close inside the session range 0.93 of the range, where 1.00 is the high Session volume 57,377,951 shares, $438,367,546 Relative volume 3.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
87	LASE	+22.32%	2023-12-21 against the close of 2023-12-20 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership	Laser Photonics Receives Order From Fluor Corporation for MarkStar Pro Laser Marking System 12/21/2023 07:00 ET premarket	Day +1 +28.57% 2023-12-22 Day +5 +5.36% 2023-12-29 Best close within 5 +28.57% 2023-12-22 76.0% of the move was gone five sessions later. Month end +5.36% on 2023-12-29
Close before and after $1.12 to $1.37 split-adjusted Session open, high, low $1.11, $1.40, $1.11 Opening gap -0.89% Close inside the session range 0.90 of the range, where 1.00 is the high Session volume 176,078 shares, $241,227 Relative volume 2.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
88	HUBC	+22.32%	2023-12-01 against the close of 2023-11-30 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	HUB Security and Blackswan Technologies to collaborate on providing a Cyber enterprise solution for one of largest EU banks 12/01/2023 07:31 ET premarket	Day +1 +8.07% 2023-12-04 Day +5 +2.15% 2023-12-08 Best close within 5 +11.67% 2023-12-05 90.4% of the move was gone five sessions later. Month end -6.87% on 2023-12-29
Close before and after $349,500.00 to $427,500.00 split-adjusted Session open, high, low $600,000.00, $675,000.00, $375,000.00 Opening gap +71.67% Close inside the session range 0.18 of the range, where 1.00 is the high Session volume 47 shares, $20,092,500 Relative volume 23.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
89	LAES	+21.74%	2023-12-28 against the close of 2023-12-27 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Crypto & Treasury	SEALSQ’s Post-Quantum Semiconductor Technology Fortifies Cryptocurrency Security 12/28/2023 07:00 ET premarket	Day +1 +11.30% 2023-12-29 Day +5 +17.39% 2024-01-05 Best close within 5 +23.48% 2024-01-03 20.0% of the move was gone five sessions later. Month end +11.30% on 2023-12-29 This month ended before the fifth session after the move.
Close before and after $1.15 to $1.40 split-adjusted Session open, high, low $1.76, $2.03, $1.26 Opening gap +53.04% Close inside the session range 0.18 of the range, where 1.00 is the high Session volume 50,377,402 shares, $70,528,363 Relative volume 384.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
90	VIRC	+21.40%	2023-12-08 against the close of 2023-12-07 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Virco Reports Record 3rd Quarter and YTD Results 12/08/2023 07:00 ET premarket	Day +1 +28.96% 2023-12-11 Day +5 +49.79% 2023-12-15 Best close within 5 +49.79% 2023-12-15 Five sessions later the move was 132.7% bigger, at +49.79%. Month end +71.61% on 2023-12-29
Close before and after $7.01 to $8.51 split-adjusted Session open, high, low $7.99, $8.75, $7.73 Opening gap +13.98% Close inside the session range 0.76 of the range, where 1.00 is the high Session volume 675,086 shares, $5,744,982 Relative volume 9.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
91	GCT	+21.40%	2023-12-01 against the close of 2023-11-30 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	GigaCloud Technology Inc Announces Third Quarter 2023 Financial Results 11/30/2023 16:05 ET after hours	Day +1 +26.34% 2023-12-04 Day +5 +37.14% 2023-12-08 Best close within 5 +40.33% 2023-12-06 Five sessions later the move was 73.6% bigger, at +37.14%. Month end +88.22% on 2023-12-29
Close before and after $9.72 to $11.80 split-adjusted Session open, high, low $10.96, $12.27, $9.90 Opening gap +12.76% Close inside the session range 0.80 of the range, where 1.00 is the high Session volume 2,494,806 shares, $29,438,711 Relative volume 6.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
92	PLAB	+21.31%	2023-12-13 against the close of 2023-12-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Photronics Reports Full Year and Fourth Quarter Fiscal 2023 Results 12/13/2023 06:30 ET premarket	Day +1 +34.49% 2023-12-14 Day +5 +36.62% 2023-12-20 Best close within 5 +41.47% 2023-12-19 Five sessions later the move was 71.8% bigger, at +36.62%. Month end +45.03% on 2023-12-29
Close before and after $21.63 to $26.24 split-adjusted Session open, high, low $23.88, $26.39, $23.37 Opening gap +10.40% Close inside the session range 0.95 of the range, where 1.00 is the high Session volume 2,494,574 shares, $65,457,622 Relative volume 8.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
93	PHR	+21.22%	2023-12-06 against the close of 2023-12-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Phreesia Announces Third Quarter Fiscal 2024 Results 12/05/2023 16:03 ET after hours	Day +1 +21.15% 2023-12-07 Day +5 +42.58% 2023-12-13 Best close within 5 +42.58% 2023-12-13 Five sessions later the move was 100.7% bigger, at +42.58%. Month end +56.95% on 2023-12-29
Close before and after $14.75 to $17.88 split-adjusted Session open, high, low $18.16, $19.04, $17.38 Opening gap +23.12% Close inside the session range 0.30 of the range, where 1.00 is the high Session volume 2,875,386 shares, $51,411,902 Relative volume 7.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
94	BNED	+20.95%	2023-12-07 against the close of 2023-12-06 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Barnes & Noble Education Reports Second Quarter Fiscal Year 2024 Financial Results 12/06/2023 16:01 ET after hours	Day +1 +17.14% 2023-12-08 Day +5 +25.71% 2023-12-14 Best close within 5 +25.71% 2023-12-14 Five sessions later the move was 22.7% bigger, at +25.71%. Month end +41.90% on 2023-12-29
Close before and after $105.00 to $127.00 split-adjusted Session open, high, low $130.50, $148.00, $126.00 Opening gap +24.29% Close inside the session range 0.05 of the range, where 1.00 is the high Session volume 75,244 shares, $9,555,988 Relative volume 62.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
95	KMDA	+20.87%	2023-12-06 against the close of 2023-12-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership	Kamada Announces its Largest Commercial Agreement; A Strategic Engagement with Kedrion for U.S. Distribution of KEDRAB® including $180 Million of Revenues Over First Four Years 12/06/2023 07:00 ET premarket	Day +1 +21.69% 2023-12-07 Day +5 +20.66% 2023-12-13 Best close within 5 +21.69% 2023-12-07 1.0% of the move was gone five sessions later. Month end +26.45% on 2023-12-29
Close before and after $4.84 to $5.85 split-adjusted Session open, high, low $5.60, $6.35, $5.60 Opening gap +15.70% Close inside the session range 0.33 of the range, where 1.00 is the high Session volume 2,385,152 shares, $13,953,139 Relative volume 194.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
96	IPA Also on the opposite board this month on both boards	+20.83%	2023-12-14 against the close of 2023-12-13 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	IPA Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2024* 12/14/2023 08:01 ET premarket	Day +1 +15.00% 2023-12-15 Day +5 +7.50% 2023-12-21 Best close within 5 +15.00% 2023-12-15 64.0% of the move was gone five sessions later. Month end +42.50% on 2023-12-29
Close before and after $1.20 to $1.45 as traded Session open, high, low $1.24, $1.45, $1.15 Opening gap +3.33% Close inside the session range 1.00 of the range, where 1.00 is the high Session volume 240,394 shares, $348,571 Relative volume 4.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
97	CIFR	+20.77%	2023-12-18 against the close of 2023-12-15 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Crypto & Treasury	Cipher Mining Purchases 7.1 EH/s of New Miners and Option to Purchase an Additional 8.7 EH/s of Latest Generation Miners from Bitmain 12/18/2023 07:00 ET premarket	Day +1 +38.08% 2023-12-19 Day +5 +91.54% 2023-12-26 Best close within 5 +91.54% 2023-12-26 Five sessions later the move was 340.7% bigger, at +91.54%. Month end +58.85% on 2023-12-29
Close before and after $2.60 to $3.14 split-adjusted Session open, high, low $2.55, $3.21, $2.53 Opening gap -1.92% Close inside the session range 0.90 of the range, where 1.00 is the high Session volume 15,377,696 shares, $48,285,965 Relative volume 5.0x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
98	CNXA	+20.57%	2023-12-26 against the close of 2023-12-22 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Connexa Reports Impressive Feedback for Slinger Artificial Intelligence App 12/26/2023 07:05 ET premarket	Day +1 +11.20% 2023-12-27 Day +5 +14.34% 2024-01-03 Best close within 5 +16.57% 2024-01-02 30.3% of the move was gone five sessions later. Month end +16.17% on 2023-12-29 This month ended before the fifth session after the move.
Close before and after $0.1750 to $0.2110 as traded Session open, high, low $0.2499, $0.2600, $0.1887 Opening gap +42.80% Close inside the session range 0.31 of the range, where 1.00 is the high Session volume 23,402,352 shares, $4,937,896 Relative volume 30.4x the median of the 20 sessions before the pre-news close Baseline gap 4 calendar days from the pre-news close to the measured session
99	LMNR	+20.39%	2023-12-01 against the close of 2023-11-30 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	Limoneira Announces Process to Explore Strategic Alternatives to Maximize Value 12/01/2023 09:14 ET premarket	Day +1 +24.01% 2023-12-04 Day +5 +25.46% 2023-12-08 Best close within 5 +26.97% 2023-12-05 Five sessions later the move was 24.9% bigger, at +25.46%. Month end +35.72% on 2023-12-29
Close before and after $15.20 to $18.30 split-adjusted Session open, high, low $15.60, $19.28, $15.60 Opening gap +2.63% Close inside the session range 0.73 of the range, where 1.00 is the high Session volume 582,952 shares, $10,668,022 Relative volume 14.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
100	UPST	+20.31%	2023-12-13 against the close of 2023-12-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Mutual Security Credit Union Selects Upstart for Personal Lending 12/13/2023 09:00 ET premarket	Day +1 +27.44% 2023-12-14 Day +5 +22.90% 2023-12-20 Best close within 5 +33.27% 2023-12-19 Five sessions later the move was 12.8% bigger, at +22.90%. Month end +15.10% on 2023-12-29
Close before and after $35.50 to $42.71 split-adjusted Session open, high, low $35.57, $43.00, $34.75 Opening gap +0.20% Close inside the session range 0.96 of the range, where 1.00 is the high Session volume 25,055,092 shares, $1,070,102,979 Relative volume 3.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session

NYSE and Nasdaq companies with a market capitalization of $25M or more, measured today. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today. 555 smaller events this month are held out of this month's eligible pool; switch to include them. 236 events never entered this month's eligible pool, because the ticker is a warrant, a unit, a right or a preferred rather than common stock, or carries a stored capitalization above $10 trillion, which is larger than any company has reached. Include the $5M to $25M band

1 candidate event for this board could not be anchored to a trading session and is not listed.

1 event was left out of this board because the measured session changed hands for less than $25,000 in total, so the percentage prices a handful of shares rather than a move anyone could have taken.

Company names are not shown on months older than a year, because only the current holder of each ticker is known.

In December 2023, the median gainer had given back 0.3% of its move five sessions later; the largest catalyst group was Other Announcement, 34 of the 100 events, at a median of +33.7%.

Close-to-close change on the measured trading session, against the previous close.

Which catalysts drove the board

Swipe the table sideways for the day +5 columns.

Catalyst	Events	Share of board	Median move close to close	Median at day +5	Still above the pre-news close at day +5
Other Announcement	34	34.0%	+33.7%	+26.1%	76.5% of 34
Clinical Trial Results	16	16.0%	+58.6%	+83.6%	100.0% of 16
Earnings	14	14.0%	+23.6%	+36.9%	100.0% of 14
M&A / Acquisition	12	12.0%	+50.1%	+55.7%	100.0% of 12
Contract / Partnership	8	8.0%	Fewer than 10 events in this group, so no figures are shown.

5 other catalyst types, 16 events: FDA & Regulatory, Offering / Dilution, Buyback / Dividend, Crypto & Treasury, Reverse Merger / Shell.

How much of the move survived

Horizon	Still above the pre-news close close to close	Median change since the measured close as a share of the move
Day +1	99.0% of 100	0.2% given back, of 100
Day +5	89.9% of 99	0.3% given back, of 99
Month end	90.7% of 97	8.4% further above baseline, of 97
Month end falls before day +5 for 20 of these 97 events, so this row is not a later horizon than the one above it. 97 of the 100 events have a month-end close later than the measured session; 1 has it on the measured session itself, and 2 have no month-end close.

Both figures in a row are measured over the events that have a close at that horizon, the count printed beside each of them, not over all 100 events on this board, which is why the denominators differ between rows.

Repeat runners

Some companies move on news more than once. The left list holds the ones that moved twice or more this month; the right list holds the ones that also moved in the months before it. The ranking above shows one row per move, so a name that keeps coming back is only visible here.

Moved twice or more inside December 2023

Two or more ranked moves this month, each on a different trading day.

Symbol	Measured sessions	Best move
CCCC	2Clinical Trial Results, Contract / Partnership	+135.47%
STTK	2Clinical Trial Results	+130.33%
PAPL	2Other Announcement	+50.68%

Also risen on news in earlier months

Ranked in at least two of the three months before this one. They are listed whether or not they rank this month, which is why the months are named.

Symbol	Months	Best move
GAN	2023-11, 2023-09	+82.78%
MIRA	2023-11, 2023-09	+40.06%
SKYX	2023-11, 2023-09	+31.82%
XOS	2023-11, 2023-09	+30.90%
LASEthis month too	2023-11, 2023-09	+30.32%
NEPT	2023-11, 2023-09	+25.15%
VERV	2023-11, 2023-10	+27.95%
SASI	2023-10, 2023-09	+145.45%
ORTX	2023-10, 2023-09	+95.95%
IBRX	2023-10, 2023-09	+29.75%
IMMX	2023-10, 2023-09	+26.61%
EVAX	2023-10, 2023-09	+41.67%
GLBS	2023-10, 2023-09	+18.04%
AVTX	2023-10, 2023-09	+45.47%

What the board was made of

Price before the move

Price bands are not shown on months older than a year, because the stored prices are adjusted for splits done since and a company that has reverse-split lands in a band its shares never traded in.

When the announcement landed

Volume against normal

Industry

27 other industries, 29 events

Industry not known: 32.0%

1 event on this board carries the flag for a move that ran against its own release, too few to say whether the flag predicts anything.

Against November 2023

100 events in the comparable window.

November 2023 median +30.8%, selected from the 10,119 events in that month's eligible pool

December 2023 median +32.8%, 2.0 points above November 2023. December 2023's median is taken over the 100 ranked rows, selected from the 5,619 events in that month's eligible pool.

The two windows drew on pools of very different size, so part of the gap between the medians is how deep into each pool the top hundred reaches rather than how severe the moves were.

How this ranking is measured

Close-to-close change on the measured trading session, against the previous close.

An announcement before 16:00 ET is measured on that trading day; one at or after 16:00 ET, or on a weekend, is measured on the next trading day.
One row per company and measured session. Other announcements the company made in the same session are listed inside the row.
A ranking is a coincidence of news and price on the same session, not proof that the news caused the move. Part of an intraday move can precede the announcement.
No Stated Cause marks a release in which the company itself says it knows of no reason for the move, while Other Announcement marks a release these rules could not classify.

Eligibility uses each company's capitalization today, not its capitalization at the time. Archive boards can therefore change as companies grow or shrink.

Prices are adjusted for stock splits the company has done since, so an older row's dollar figures are stated on today's share count and are not the prices that traded that day. The percentage move, the dollar volume and the relative volume are unaffected, because both prices carry the same adjustment. The session's share count carries the adjustment too, so the shares figure beside the dollar volume is that count restated on today's basis rather than the number of shares that changed hands. Where the ticker was retired the price series stops with it and no later adjustment reached it, so those rows are marked as traded and their dollars are the ones that changed hands on the day.

Market cap is not shown on months older than a year, because only today's figure exists.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

This archive starts at 2020-04, the first month with ranked moves.